Bristol-Myers Squibb (BMY) Revenue — Quarter Ended Sep 30, 2025
Revenue for the quarter was slightly lower than the immediately preceding quarter but higher than the same quarter one year earlier. The sequential decline was marginal, while the year-over-year increase reflected a modest improvement.
Key takeaway
Quarter ended Sep 30, 2025 · FY2025 Q3
Revenue for the quarter was slightly lower than the immediately preceding quarter but higher than the same quarter one year earlier. The sequential decline was marginal, while the year-over-year increase reflected a modest improvement.
Financial snapshot
Reported revenue, sequential change, year-over-year change, and trailing four-quarter revenue.
Quarter revenue
$12.2B
Revenue reported for this quarter.
Quarter-over-quarter
-0.4%
Change from the immediately preceding quarter.
Year-over-year
+2.8%
Change from the comparable year-ago quarter.
Trailing four quarters
$48B
Sum of the latest four reported quarters.
Quarterly revenue trend
The latest four reported quarters with year-over-year comparisons.
| Period ended | Revenue | Year-over-year change |
|---|---|---|
| Dec 31, 2024 | $12.3B | +7.5% |
| Mar 31, 2025 | $11.2B | -5.6% |
| Jun 30, 2025 | $12.3B | +0.6% |
| Sep 30, 2025 | $12.2B | +2.8% |
Revenue performance
Reported revenue moved lower compared to the prior quarter, reversing the small gain seen in the preceding period. The year-over-year comparison, however, showed a positive direction.
Quarterly comparison
Revenue was down slightly from the prior quarter but up from the same quarter a year ago. The trailing twelve-month revenue figure remained stable relative to recent levels.
What to watch
The sequential decline, though small, follows a period of alternating quarterly changes and warrants monitoring for any emerging trend.